Despite guideline recommendations, the use of bioprosthetic heart valves has surpassed mechanical valves, but data from a large surgical database may lead to a reassessment of that practice.

Executives expect a new label indication and a hoped-for easing of hospital capacity constraints to accelerate sales this ...

Patients aged between 50 to 70 years with a mechanical heart valve replacement had better long-term survival compared to those with a biological valve, new research has found.

A high burden of heart valve diseases is driving its expansion. India’s transcatheter aortic valve replacement (TAVR) market ...

The Medicare data contradict results from the TCW randomized trial but better represent real-world practice, say authors.

Connecticut U.S. Rep. John Larson, who inexplicably stopped speaking during a speech Monday on the House of Representatives ...

Edwards Lifesciences beat Q4 estimates with $1.39B in sales, driven by growth in TMTT, TAVR, and Surgical. The company ...

Patients aged between 50 to 70 years with a mechanical heart valve replacement had better long-term survival compared to those with a biological valve, new research led by the University of Bristol ...

Heart disease remains the leading cause of death in the United States, claiming approximately 700,000 lives each year.